HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Warfarin-associated hematomyelia.

Abstract
A 71-year-old woman on warfarin (2.5 mg daily) developed severe low back pain with reduced touch sensation and weakness of the lower limbs that progressed to complete paralysis within 28 to 30 hours. Imaging revealed bleeding at the D4 through D11 level, however the patient refused emergency laminectomy. No recovery was observed and the patient was discharged to a rehabilitation facility. Only few other cases of hematomyelia linked to anticoagulant therapy have been reported. Early diagnosis, appropriate management and immediate intervention are needed to prevent irreversible neurological sequelae. The elusive clinical features at presentation may cause an important diagnostic delay.
AuthorsGiuseppe Famularo, Maria Rosaria Sajeva, Laura Gasbarrone
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 53 Issue 6 Pg. 623-6 ( 2014) ISSN: 1349-7235 [Electronic] Japan
PMID24633035 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticoagulants
  • Antifibrinolytic Agents
  • Vitamin K
  • Warfarin
Topics
  • Aged
  • Anticoagulants (adverse effects)
  • Antifibrinolytic Agents (therapeutic use)
  • Delayed Diagnosis
  • Female
  • Humans
  • Low Back Pain (etiology)
  • Paralysis (etiology, rehabilitation)
  • Plasma
  • Spinal Cord Vascular Diseases (chemically induced, complications, diagnosis)
  • Vitamin K (therapeutic use)
  • Warfarin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: